» Articles » PMID: 39521750

Focused Ultrasound for Treatment of Epilepsy: a Systematic Review and Meta-analysis of Preclinical and Clinical Studies

Overview
Journal Neurosurg Rev
Specialty Neurosurgery
Date 2024 Nov 9
PMID 39521750
Authors
Affiliations
Soon will be listed here.
Abstract

Various preclinical and clinical studies have demonstrated the neuromodulatory and ablative effects of focused ultrasound (FUS). However, the safety and efficacy of FUS in clinical settings for treating epilepsy have not been well established. This study aims to provide a systematic review of all preclinical and clinical studies that have used FUS for the treatment of epilepsy. A systematic search was conducted using Scopus, Web of Science, PubMed, and Embase databases. All preclinical and clinical studies reporting outcomes of FUS in the treatment of epilepsy were included in the systematic review. Random-effect meta-analysis was performed to determine safety in clinical studies and seizure activity reduction in preclinical studies. A total of 24 articles were included in the study. Meta-analysis demonstrated that adverse events occurred in 13% (95% CI = 2-57%) of patients with epilepsy who underwent FUS. The frequency of adverse events was higher with the use of FUS for lesioning (36%, 95% CI = 4-88%) in comparison to neuromodulation (5%, 95% CI = 0-71%), although this difference was not significant (P = 0.31). Three-level meta-analysis in preclinical studies demonstrated a reduced spike rate in neuromodulating FUS compared to the control group (P = 0.02). According to this systematic review and meta-analysis, FUS can be considered a safe and feasible approach for treating epileptic seizures, especially in drug-resistant patients. While the efficacy of FUS has been demonstrated in several preclinical studies, further research is necessary to confirm its effectiveness in clinical practice and to determine the adverse events.

References
1.
de Boer H, Mula M, Sander J . The global burden and stigma of epilepsy. Epilepsy Behav. 2008; 12(4):540-6. DOI: 10.1016/j.yebeh.2007.12.019. View

2.
Boon P, De Cock E, Mertens A, Trinka E . Neurostimulation for drug-resistant epilepsy: a systematic review of clinical evidence for efficacy, safety, contraindications and predictors for response. Curr Opin Neurol. 2018; 31(2):198-210. DOI: 10.1097/WCO.0000000000000534. View

3.
Scharfman H . The neurobiology of epilepsy. Curr Neurol Neurosci Rep. 2007; 7(4):348-54. PMC: 2492886. DOI: 10.1007/s11910-007-0053-z. View

4.
Lopez Gonzalez F, Rodriguez Osorio X, Gil-Nagel Rein A, Carreno Martinez M, Serratosa Fernandez J, Villanueva Haba V . Drug-resistant epilepsy: definition and treatment alternatives. Neurologia. 2014; 30(7):439-46. DOI: 10.1016/j.nrl.2014.04.012. View

5.
Englot D, Chang E . Rates and predictors of seizure freedom in resective epilepsy surgery: an update. Neurosurg Rev. 2014; 37(3):389-404. PMC: 5257205. DOI: 10.1007/s10143-014-0527-9. View